Search

everythinglearnresearchcommunity

for

Search:↓

Hair cortisol levels peak in the third trimester and decline postpartum.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Apigenin, found in plants and vegetables, has many health benefits, including anti-inflammatory, antioxidant, and anticancer effects.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.